About Us

Amalgam Capital was founded in 2020 by the entrepreneurs behind SLKone, a management consulting firm dedicated to bridging strategy, leadership, and knowledge through data-driven solutions. While advising clients on operational improvements, we recognized a gap in the middle market: businesses needed investors who truly understood operations, not just spreadsheets.

As a family-driven independent sponsor with offices in New York, Philadelphia, Atlanta, and Raleigh-Durham, Amalgam combines patient capital with hands-on operational expertise to transform undervalued businesses into market leaders while preserving the legacy that founders worked so hard to build.

Operators at Our Core

Our partners have led global turnarounds, managed factory floors, implemented lean processes, and driven strategic M&A. We understand business challenges because we've solved them ourselves.

SLKone's Proven Methodologies

Our portfolio companies benefit from the same battle-tested operational playbooks that have delivered billions in value for global organizations. As one of Financial Services Review's Top 10 M&A Consulting Firms (2022), SLKone's analytics-driven approach to integration and performance improvement forms the foundation of our investment thesis.

Family-First Culture

Three of our partners are family (a father and two sons), and the others are long-time colleagues who operate with a 'no egos, no ivory tower' philosophy. This culture translates into how we work with portfolio companies – with respect, collaboration, and shared success.

Independent Sponsor Model

Without the pressures of a traditional fund, we can focus on creating sustainable value rather than financial engineering for quick exits. Our typical holding period of 4-7 years aligns with natural business cycles, not artificial deadlines.

Our mission is to transform undervalued businesses into market leaders by combining operational excellence with patient capital, preserving founder legacies while delivering exceptional returns for all stakeholders.